AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $38,000 | -42.4% | 16,599 | -27.5% | 0.00% | – |
| Q3 2021 | $66,000 | -35.3% | 22,905 | -15.1% | 0.00% | – |
| Q2 2021 | $102,000 | +12.1% | 26,963 | 0.0% | 0.00% | – |
| Q1 2021 | $91,000 | +26.4% | 26,963 | +5.5% | 0.00% | – |
| Q4 2020 | $72,000 | -60.7% | 25,552 | -64.9% | 0.00% | -100.0% |
| Q3 2020 | $183,000 | -78.8% | 72,802 | +14.6% | 0.00% | -75.0% |
| Q2 2020 | $863,000 | +75.8% | 63,550 | -1.9% | 0.00% | +33.3% |
| Q1 2020 | $491,000 | +20.0% | 64,793 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $409,000 | +42.0% | 64,793 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $288,000 | -21.1% | 73,401 | -2.7% | 0.00% | 0.0% |
| Q2 2019 | $365,000 | -40.9% | 75,401 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $618,000 | +60.5% | 75,401 | +8.4% | 0.00% | +33.3% |
| Q4 2018 | $385,000 | – | 69,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |